Sickle cell disease

37
Sickle cell disease This is an inherited multisystem disorder caused by abnormal properties of RBCs containing HbS . This results from mutation in the β-globin gene that changes the 6th amino acid from glutamic acid to valine

description

Sickle cell disease. This is an inherited multisystem disorder caused by abnormal properties of RBCs containing HbS. This results from mutation in the β-globin gene that changes the 6th amino acid from glutamic acid to valine. Pathophysiology. - PowerPoint PPT Presentation

Transcript of Sickle cell disease

Page 1: Sickle cell disease

Sickle cell disease

This is an inherited multisystem disorder caused by abnormal properties of RBCs containing HbS .

This results from mutation in the β-globin gene that changes the 6th amino acid from glutamic acid to valine

Page 2: Sickle cell disease

Pathophysiology*Hb S arises from a mutation substituting

thymine for adenine in the sixth codon of the beta-chain gene, GAG to GTG. This causes coding of valine instead of glutamate in

position 6 of the Hb beta chain .

The resulting Hb has the physical properties of forming polymers under deoxy conditions. It also exhibits changes in solubility and molecular stability. These properties are responsible for the profound clinical expressions of the sickling syndromes.

 

Page 3: Sickle cell disease

Inheritance--- AR HbS polymerizes reversibly when deoxygenated forming a gelatinous network of fibrous polymers that stiffen RBC membrane, ↑ viscosity, and causes RBC dehydration due to potassium leakage & calcium influx. These changes cause the characteristic sickle shape. They lose their pliability that is needed to pass through the capillaries circulation. Their cell membrane is sticky & adherent to endothelium especially the reticulocytes. This leads to

vaso-occlusion & premature RBC destruction (hemolysis) .HbS is also unstable & susceptible to oxidant stress.

Page 4: Sickle cell disease

Epidemiology USA prevalence = 8-10% among black newborn.

West Africa = 25-30% .

USA pregnancy at risk = 4000-5000/year .

Africa = 120000/year born with sickle cell disease

USA = 50000-60000 living patients.

Page 5: Sickle cell disease

S&S Asymptomatic (sickle cell trait = Hb-AS)

Sickle cell disease is seen in homozygous state.

Chronic hemolytic anemia, recurrent painful episodes, organ dysfunction (sickle cell disease = Hb-SS)

Page 6: Sickle cell disease

Anemia Hemolytic anemia (most).

Mean life span 17 days.

Hct= 15-30% + significant reticulocytosis .

Most severe in Hb-SS & Hb-Sβ˚thalassemia .

Milder in Hb-Sβ+ thalassemia & Hb-SC disease. ---- Low erythropoietin production .

Granulocytosis (has significant relation to mortality rate).

Page 7: Sickle cell disease

Painful Crises Acute painful episode is often 1st symptom.

Caused by vaso-occlusion .

Frequent episodes & frequent hospitalization .

Highest frequency in 3rd & 4th decades.

Page 8: Sickle cell disease

Factors ass with freq pain 1 .high Hb level

2 .α-thalassemia

3 .Low Hb F

4 .Sleep apnea .

This can be ↓ by chronic transfusion therapy.

Page 9: Sickle cell disease

Pptating factors Cold exposure ,

Dehydration ,

Infection,

Stress ,

Menses ,

Alcohol consumption

&most of the times Unknown.

Page 10: Sickle cell disease

Site Any area of the body can be affected.

Most commonly the back, chest, extremities & abdomen . Duration: few days

Severity: varies from mild to agonizing pain .

Ass signs: fever, swelling, tenderness, tachypnea,

hypertension, nausea & vomiting .

Lab. Indicators: ↑ acute phase reactants, ↑ SLDH, IL-1, TNF, & ↑ serum viscosity.

Page 11: Sickle cell disease

Other Crises 1) Hemolytic crisis

Sudden exacerbation of anemia ,

↑reticulocytosis, & serum bilirubin level .

---ass with coexistent G6PD def

Page 12: Sickle cell disease

2 (Aplastic crisis Transient arrest of erythropoiesis .

--Abrupt ↓ of Hb, reticulocytes count & RBC precursors in BM .

-- Duration – a few days .

-- Cause – infection e.g. parvovirus B19

--BM necrosis.

Page 13: Sickle cell disease

3 (Sequestration crisis –in the spleen (sometimes in liver) .

--Children < 4 years age, Hb-SC adults, Hb-

Sβ+ thalassemia .

-- Sudden exacerbation of anemia, reticulocytosis, & tender enlarging spleen (sometimes hypovolemia)

Page 14: Sickle cell disease

4 (Megaloblastic crisis

due to folate def because of hemolysis & cell turnover.

Page 15: Sickle cell disease

5 (Hepatic crisis

Vaso-occlusion causing ischemia.

Other causes of anemia --- renal failure ass.

Page 16: Sickle cell disease

Organ Dysfunction *Auto-splenectomy -- due to repeated splenic

infarcts . *Growth retardation – Wt affected more than height .

-- Skeletal maturation delayed . -- Retarded sexual maturation in ♂

due to primary hypogonadism, hypopituitarism & hypothalamic insufficiency.

Page 17: Sickle cell disease

*Infection Major cause of morbidity & mortality .

-- Strept pnemoniae is most common cause of bacteremia.

-- H influenzae type b is the 2nd, affects older children & less fulminant.

-- G-ve bacteria e.g. E coli in older pts -- meningitis -- S pn, H infl

-- Bact pneumonia causing acute chest syndrome .

-- Osteomyelitis – Salmonella spp.

Page 18: Sickle cell disease

CNS TIA, cerebral infarction, hemorrhage, seizures

& coma .

-- Cerebral thrombosis 70%.

Page 19: Sickle cell disease

*Pulmonary Acute chest syndrome – dyspnea, chest pain, fever, tachypnea, leucocytosis, radiologic

pulmonary infiltrates .

-- usually bacterial (sometimes atypical ) .

--restrictive lung disease

--pulmonary hypertension

Page 20: Sickle cell disease

*Hepatobiliary

--Gall stones (pigmented)

-- Liver dysfunction – vasoocclusion, inf, iron overload

--cirrhosis.

Page 21: Sickle cell disease

*Obst/Gyn

Impaired placental blood flow is the major concern

-- Spontaneous abortion -- Intrauterine growth

retardation & death . -- low birth wt .

-- Preeclampsia -- Oral contraceptives are safe

& effective

Page 22: Sickle cell disease

*Renal

--Decreased urinary conc ability

-- papillary infarct

-- RTA

--CRF

Page 23: Sickle cell disease

*Priapism

–sustained unwanted painful erection of penis .

-- may be recurrent & may lead to impotence

Page 24: Sickle cell disease

*Ocular

Retinal artery occlusion ,

retinal infarct,

retinal detachment & hemorrhage.

Page 25: Sickle cell disease

*Bone

Avascular necrosis of femoral head, hand & foot, vertebrae & other bones .

-- Osteomyelitis.

-- arthritis .

-- BM necrosis.

Page 26: Sickle cell disease

*Skin – Leg ulcers – ischemic or traumatic, above malleoli & often

bilateral. Resistant to healing & recur .

--Myofascial syndrome .

*Cardiac – MI in the absence of CAD.

Page 27: Sickle cell disease

Dx

CBC – anemia, reticulocytosis, Granulocytosis .Blood film – ISCs RBCs, Howell-Jolly bodies

due to asplenia .Sickling test – now only historical .Hb- electrophoresis ---- HbS , HbF, ↓ HbA .

Solubility test (Sickledex) – distinguishes HbS which is not soluble .

PCR – antenatal Dx SUCB ↑, SLDH ↑, S haptoglobin.↓

Page 28: Sickle cell disease

℞ 1 (Health care maintenance --- routine clinical visits &

lab exam --- Blood bank file .

--- Counseling regarding dis, genetics, psychosocial issues .

--- Folic acid 1mg/d orally --- TCD noninvasive surveillance of cerebral

blood flow to predict impending CVA . --- Retinal evaluation at school age regularly.

--- Oral contraception, pelvic exam --- Immunization using conjugated vaccines

for S pneumoniae & H influenzae type b every 5 years.

Page 29: Sickle cell disease

2 (Infection ----outpatient ceftriaxone for febrile children.

---Septicemia needs hospitalization, C&S blood &

CSF

--- meningitis – cover S pn & H infl for 2 weeks .

--- Acute chest synd – Cefuroxime & erythromycin covering Mycop pn & chlamydia .

---Osteomyelitis – anti salmonella antibiotics for 2-6

weeks + surgical drainage or sequestrectomy.

Page 30: Sickle cell disease

3 (Blood Transfusion

---For volume replacement, Aplastic crisis, and to prevent CVA & imminent complications such as acute chest

syndrome . ---- Not needed for painful

crisis. --- Preop BlT needed . --- Exchange BlT – for

emergencies

Page 31: Sickle cell disease

4 (Pain Management

Painful crisis –

--Hydration – IV fluid .

--aggressive analgesics e.g. morphine, NSAID .

--- Local anesthesia.

--Antidepressant

Page 32: Sickle cell disease

5 (Hydroxyurea

---induce Hb F production ---Ribonucleotide reductase inhibitor

↓ ---painful episodes, acute chest syndrome

↓ --- BlT needed --- improve RBC hydration &

deformability, ↓ endothelial sickle cell adherence & PMN count.

Page 33: Sickle cell disease

6 (New ttt ---Clotrimazole, Mg supplements (inhibit

Gardos pathway) --- Artificial surfactant e.g. poloxamer 188 --- Nitric oxide acute chest synd & painful

episodes . --- Warfarin & mini dose heparin

--- Methyl prednisolone pain relief but with rebound

--- Valproic acid

Page 34: Sickle cell disease

7 (BMT

•8 (Gene therapy

Page 35: Sickle cell disease
Page 36: Sickle cell disease
Page 37: Sickle cell disease